{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-005886","form_type":"8-K","ticker":"EDIT","cik":"0001650664","company_name":"Editas Medicine, Inc.","filed_at":"2023-04-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.841511+00:00","generated_at":"2026-06-17T02:40:11.644714+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Editas Medicine appoints Elliot Levy, M.D. as independent director","bullets":["Dr. Levy appointed as class I director; Board size increased by one member effective April 11, 2023.","He will serve on the Audit Committee and Science and Technology Committee.","Levy is a Venture Partner at 5AM Ventures; former SVP of R&D at Amgen; boards of Omega Therapeutics and NuCana.","Annual cash compensation: $40,000 board + $7,500 Audit + $5,000 Science & Tech; option for 50,000 shares vesting over 3 years.","No arrangement or understanding with any other person pursuant to which he was selected."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-005886","json":"https://secwatch.observer/filing/0001558370-23-005886.json","markdown":"https://secwatch.observer/filing/0001558370-23-005886.md","text":"https://secwatch.observer/filing/0001558370-23-005886.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1650664/000155837023005886/0001558370-23-005886-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1650664/000155837023005886/edit-20230411x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T02:40:11.644714+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"da47c8c314","claim":"Elliot Levy was appointed as Independent Director at Editas Medicine, Inc..","evidence_excerpt":"appointed Elliot Levy, M.D. as an independent director, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1650664/000155837023005886/0001558370-23-005886-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Independent Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}